Windlas Biotech Ltd

NSE:WINDLASHealthcare

₹906.10−1.23%At closeAt close · Mon 19 Oct · ≈ AED 35.01 · Market cap $199.37M

INR billions	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	YoY
Cash & cash equivalents	0.2	0.0	0.0	0.1	0.0	0.0	+327.8%
Cash & short-term investments	0.5	1.8	1.3	2.0	2.4	2.7	+12.4%
Receivables	0.8	1.1	1.2	1.4	1.7	2.3	+36.3%
Inventory	0.4	0.6	0.7	0.6	0.8	0.6	−24.0%
Total current assets	1.9	3.8	3.5	4.3	5.3	6.3	+19.4%
Property, plant & equipment	1.0	1.0	1.2	1.8	2.2	2.7	+19.9%
Goodwill & intangibles	0.0	0.0	0.0	0.0	0.1	0.1	+1.9%
Long-term investments	0.0	0.0	0.1	0.0	0.0	0.1	+540.7%
Total assets	3.0	4.9	5.3	6.3	7.6	9.1	+19.3%
Payables	0.4	0.6	0.9	1.3	1.7	2.4	+42.6%
Short-term debt	0.3	0.1	0.0	0.0	0.3	0.3	+10.2%
Total current liabilities	0.9	0.9	1.2	1.7	2.5	3.2	+28.7%
Long-term debt	0.0	0.0	0.0	0.0	0.0	0.0	—
Total debt	0.3	0.1	0.0	0.0	0.3	0.4	+8.1%
Net debt	0.2	0.1	0.0	(0.0)	0.3	0.3	+3.9%
Deferred revenue	0.0	0.0	0.0	0.0	0.0	0.0	—
Total liabilities	1.0	1.0	1.3	1.8	2.5	3.3	+28.2%
Total equity	2.0	3.9	4.0	4.5	5.1	5.8	+14.8%
Retained earnings	1.0	1.4	1.8	2.3	2.7	3.3	+19.8%

INR billionsUpdated Tue 31 Mar ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.